1-5 of 5
Kathryn Kennedy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Behind the blood-brain barrier: Contemporary screening practice patterns and trends of central nervous system involvement in acute myeloid leukemia treated with intensive regimens and hypomethylating agent/venetoclax

Free
Jamila Mammadova, Melanie Naranjo, Sarah Profitt, Bradley Yelvington, Callee Brooks, Kian Rahbari, Kathryn Kennedy, Erica Mittlebeeler, Somedeb Ball, Michael Savona, Ashwin Kishtagari, Sanjay Mohan, Kateryna Fedorov
Journal: Blood
Blood (2025) 146 (Supplement 1): 1621.
https://doi.org/10.1182/blood-2025-1621
Published: 2025
Journal Articles

Oral decitabine-cedazuridine versus parenteral hypomethylating agents in treatment-Naïve TP53-mutated Myelodysplastic Syndromes

Free
Parth Patel, Michael Canonico, Hayley Hawkins, Michael Zargari, Kathryn Kennedy, Katherine Walsh, Erica Mittlebeeler, Bradley Yelvington, Laura Lee, Emily F. Mason, Kateryna Fedorov, Ashwin Kishtagari, Sanjay Mohan, Michael Savona, Somedeb Ball
Journal: Blood
Blood (2025) 146 (Supplement 1): 7389.
https://doi.org/10.1182/blood-2025-7389
Published: 2025
Journal Articles

Addition of venetoclax to hypomethylating agent offers limited incremental benefit for patients with treatment-naïve TP53-mutated myelodysplastic syndromes

Free
Michael Canonico, Parth Patel, Hayley Hawkins, Kateryna Fedorov, Katherine Walsh, Kathryn Kennedy, Erica Mittlebeeler, Sarah Profitt, Sanjay Mohan, Emily F. Mason, Ashwin Kishtagari, Michael Savona, Somedeb Ball
Journal: Blood
Blood (2025) 146 (Supplement 1): 7388.
https://doi.org/10.1182/blood-2025-7388
Published: 2025
Journal Articles

Impact of RAS mutations on outcomes in newly diagnosed AML patients

Free
Melanie Naranjo, Jamila Mammadova, Sarah Profitt, Bradley Yelvington, Callee Brooks, Kathryn Kennedy, Erica Mittlebeeler, Ashwin Kishtagari, Somedeb Ball, Sanjay Mohan, Michael Savona, Kateryna Fedorov
Journal: Blood
Blood (2025) 146 (Supplement 1): 7026.
https://doi.org/10.1182/blood-2025-7026
Published: 2025
Journal Articles

High remission rates with FLAG-ida-venetoclax in acute myeloid leukemia: “Less is More” on days of venetoclax in the intensive regimen

Free
Kateryna Fedorov, Kathryn Kennedy, Erica Mittlebeeler, Sarah Profitt, Bradley Yelvington, Callee Brooks, Ashwin Kishtagari, Sanjay Mohan, Michael Savona, Somedeb Ball
Journal: Blood
Blood (2025) 146 (Supplement 1): 1666.
https://doi.org/10.1182/blood-2025-1666
Published: 2025